ATI Physical Therapy, Inc.
ATIPOTCHealthcare
$0.68
+$0.00(+0.00%)
Market Cap$2977763
P/E Ratio—
52W High$6.49
52W Low$0.36
ATI Physical Therapy, Inc. (ATIP) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ATIP · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2025Report Date: Mar 18, 2025EPS Actual
-$2.14
Est. -$3.20 · +33.1%
Revenue
$0.19B
Est. $0.19B · +2.4%
Fiscal Period
Q1 FY2025
FY ends December
Report Date
Mar 18, 2025
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
ATIP reports quarterly as a OTC-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$93.32
Rev. $1001.5B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$93.32
Rev. Est.$1001.5B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q1 FY2026 | Mar 16, 2026 | -$2.77 | — | — | — | $0.20B | — |
| ◌ Q3 FY2025 | Aug 6, 2025 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | May 30, 2025 | — | — | — | — | — | — |
| ▲ Q1 FY2025 | Mar 18, 2025 | -$3.20 | -$2.14 | +33.1% | $0.19B | $0.19B | +2.4% |
| ▼ Q4 FY2024 | Nov 4, 2024 | -$3.12 | -$4.89 | -56.7% | $0.19B | $0.19B | +2.2% |
| ▲ Q3 FY2024 | Aug 5, 2024 | -$2.63 | -$2.43 | +7.6% | $0.19B | $0.19B | -1.0% |
| ▼ Q2 FY2024 | May 6, 2024 | -$4.50 | -$4.61 | -2.4% | $0.18B | $0.18B | -0.2% |
| ▲ Q1 FY2024 | Feb 26, 2024 | -$3.17 | -$2.15 | +32.2% | $0.18B | $0.18B | +2.8% |
Q1 FY2026
Mar 16, 2026
EPS Actual
—
EPS Est.
-$2.77
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 6, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 30, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 18, 2025Beat
EPS Actual
-$2.14
EPS Est.
-$3.20
EPS Surpr.
+33.1%
Revenue
$0.19B
Q4 FY2024
Nov 4, 2024Miss
EPS Actual
-$4.89
EPS Est.
-$3.12
EPS Surpr.
-56.7%
Revenue
$0.19B
Q3 FY2024
Aug 5, 2024Beat
EPS Actual
-$2.43
EPS Est.
-$2.63
EPS Surpr.
+7.6%
Revenue
$0.19B
Q2 FY2024
May 6, 2024Miss
EPS Actual
-$4.61
EPS Est.
-$4.50
EPS Surpr.
-2.4%
Revenue
$0.18B
Q1 FY2024
Feb 26, 2024Beat
EPS Actual
-$2.15
EPS Est.
-$3.17
EPS Surpr.
+32.2%
Revenue
$0.18B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-2.77 | $-2.77 | $-2.77 | 1 |
| Q3 FY2025 | $-2.88 | $-2.88 | $-2.88 | 1 |
| Q2 FY2025 | $-1.72 | $-1.72 | $-1.72 | 1 |
| Q1 FY2025 | $-3.92 | $-3.92 | $-3.92 | 1 |
| Q4 FY2024 | $-3.20 | $-3.20 | $-3.20 | 1 |
| Q3 FY2024 | $-3.08 | $-3.08 | $-3.08 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2025 | $0.2B | $0.2B | $0.2B | 1 |
| Q2 FY2025 | $0.2B | $0.2B | $0.2B | 1 |
| Q1 FY2025 | $0.2B | $0.2B | $0.2B | 1 |
| Q4 FY2024 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2024 | $0.2B | $0.2B | $0.2B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2025 | Mar 18, 2025 | +33.1% | $1.25 | $1.27 | +1.60% |
| ▼ Q4 FY2024 | Nov 4, 2024 | -56.7% | $5.50 | $5.15 | -6.36% |
| ▲ Q3 FY2024 | Aug 5, 2024 | +7.6% | $6.55 | $6.44 | -1.68% |
| ▼ Q2 FY2024 | May 6, 2024 | -2.4% | $4.63 | $5.00 | +7.99% |
| ▲ Q1 FY2024 | Feb 26, 2024 | +32.2% | $6.59 | $7.48 | +13.51% |
| ▼ Q4 FY2023 | Nov 6, 2023 | -8.3% | $7.73 | $7.85 | +1.55% |
| ▼ Q3 FY2023 | Aug 7, 2023 | -351.4% | $7.49 | $7.92 | +5.74% |
| ▼ Q2 FY2023 | May 8, 2023 | -87.5% | $12.50 | $13.20 | +5.60% |
Q1 FY2025+1.60%
Report Date
Mar 18, 2025
EPS Beat/Miss
+33.1%
Price Before
$1.25
Price After
$1.27
Q4 FY2024-6.36%
Report Date
Nov 4, 2024
EPS Beat/Miss
-56.7%
Price Before
$5.50
Price After
$5.15
Q3 FY2024-1.68%
Report Date
Aug 5, 2024
EPS Beat/Miss
+7.6%
Price Before
$6.55
Price After
$6.44
Q2 FY2024+7.99%
Report Date
May 6, 2024
EPS Beat/Miss
-2.4%
Price Before
$4.63
Price After
$5.00
Q1 FY2024+13.51%
Report Date
Feb 26, 2024
EPS Beat/Miss
+32.2%
Price Before
$6.59
Price After
$7.48
Q4 FY2023+1.55%
Report Date
Nov 6, 2023
EPS Beat/Miss
-8.3%
Price Before
$7.73
Price After
$7.85
Q3 FY2023+5.74%
Report Date
Aug 7, 2023
EPS Beat/Miss
-351.4%
Price Before
$7.49
Price After
$7.92
Q2 FY2023+5.60%
Report Date
May 8, 2023
EPS Beat/Miss
-87.5%
Price Before
$12.50
Price After
$13.20
Avg Beat Reaction+4.48%
Avg Miss Reaction+2.90%
Beat Rate3 / 8 quarters
Largest Move+13.51% (Q1 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ATIP ends December
ATI Physical Therapy, Inc. (ATIP) most recently reported earnings on March 18, 2025 for Q1 FY2025, posting EPS of $-2.14 — beating the analyst consensus of $-3.20 by +33.1%. The next ATIP earnings date is expected around September 1, 2026.
Each quarter, investors track ATIP earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ATIP revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ATIP's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ATIP earnings · 5 questionsATI Physical Therapy, Inc.'s next earnings report is expected around September 1, 2026. ATIP typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ATIP historically reports after market close (AMC).
ATIP earnings datewhen is ATIP earningsATIP next earnings datewhen does ATIP report earningsATIP earnings calendar
▸ Source: FMP · ATI Physical Therapy, Inc. SEC filings · US GAAP · ATI Physical Therapy, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026